Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ross Products

This article was originally published in The Tan Sheet

Executive Summary

Abbott Labs nutritional division net sales up slight 1.5% to $511 mil. in Q2, feeling impact of "unusually high" promotional spending by competitors and accounting procedure change that reduced quarterly sales by 1%. Accounting adjustment change requiring coupons, rebates be reclassified from SG&A expenses to deduction from sales was implemented in Q4 and impacts comparisons to year-ago quarters, company notes (1"The Tan Sheet" Feb. 5, p. 14). Ross predicts "mid-single digit" sales growth for remainder of 2001. Firm says it will refer to recent infant formula study showing Similac with Iron promotes greater bone density than Mead Johnson's Enfamil with Iron in upcoming promotions

You may also be interested in...



Coupon Accounting Adjustment Revenue Impact Cited To Analysts

Pharmaceutical and consumer product firms are beginning to report the financial effects of accounting procedures that change the way some companies account for coupons, rebates and other incentives in income statements.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

LL1135415

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel